SOME FACTORS ASSOCIATED WITH AND THE CONSEQUENCES OF HIGH-SENSITIVITY TROPONIN I ELEVATION IN SEPTIC SHOCK

Luân Nguyễn Thành, Nhân Nguyễn Phước

Main Article Content

Abstract

Introduction: The factors associated with and the consequences of elevated high-sensitivity troponin I (hs-TnI) levels in septic shock remain unclear. Objectives: To investigate common factors associated with hs-TnI elevation and its relationship with clinical outcomes in patients with septic shock. Methods: A cross-sectional descriptive study was conducted on 136 patients diagnosed with septic shock based on the Sepsis-3 definition, admitted to the Intensive Care Unit of Hoan My Cuu Long Hospital from January 2023 to October 2024. Results: The prevalence of hs-TnI elevation at diagnosis was 61% after gender adjustment, with a median level of 36 ng/L (interquartile range: 10.0 – 175.9). Factors associated with hs-TnI elevation included positive blood cultures, SOFA score at diagnosis, serum procalcitonin, and hemoglobin levels. In multivariate analysis, serum procalcitonin remained significantly associated with hs-TnI elevation (OR = 1.005, 95% CI: 1.001 – 1.010, p = 0.020). hs-TnI elevation was associated with an increased rate of mechanical ventilation (56.6% vs. 32.1%, p = 0.009), higher in-hospital mortality (41% vs. 22.6%, p = 0.044), and higher 30-day mortality (48.2% vs. 28.3%, p = 0.034). Conclusion: Serum procalcitonin is a factor associated with hs-TnI elevation in patients with septic shock in multivariate analysis. Elevated hs-TnI levels are associated to increased mechanical ventilation requirements and higher mortality rates.

Article Details

References

1. Babuin L, Vasile VC, Rio Perez JA, et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med. 2008;36(3):759-765. DOI:10.1097/CCM. 0B013E318164E2E4
2. McGrade P, Jones C, Haneke T, et al. Characteristics and Outcomes of Hospitalized Patients Undergoing Troponin Testing. ARC Journal of Cardiology. 2024;9:01-04. https://doi. org/10.20431/2455-5991.0901001
3. Garcia MA, Bosch NA, Peltan ID, Walkey AJ. Variation in Troponin I Measurement and the Cardiovascular Management Approach Following Elevated Troponin I Among Critically Ill Patients With Sepsis. Crit Care Explor. 2023;5(1):e0842. DOI:10.1097/CCE.0000000000000842
4. Garcia MA, Rucci JM, Thai KK, et al. Association between Troponin I Levels during Sepsis and Postsepsis Cardiovascular Complications. Am J Respir Crit Care Med. 2021; 204(5): 557-565. DOI:10.1164/rccm.202103-0613OC
5. Vallabhajosyula S, Sakhuja A, Geske JB, et al. Role of Admission Troponin-T and Serial Troponin-T Testing in Predicting Outcomes in Severe Sepsis and Septic Shock. J Am Heart Assoc. 2017;6(9). DOI:10.1161/JAHA.117.005930
6. Zheng P, Wang X, Guo T, et al. Cardiac troponin as a prognosticator of mortality in patients with sepsis: A systematic review and meta-analysis. Immun Inflamm Dis. 2023; 11(9):e1014. DOI:10.1002/iid3.1014
7. Zochios V, Valchanov K. Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review. J Intensive Care Soc. 2015;16(1):52-57. DOI:10. 1177/1751143714555303
8. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016; 315(8): 801-810. DOI:10.1001/jama. 2016.0287
9. ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem. 2000; 46(5):650-657.
10. Phan Đăng Hải. Nghiên cứu Giá trị Tiên lượng tử vong của Troponin T độ nhạy cao ở bệnh nhân nhiễm khuẩn huyết. Journal of 108 - Clinical Medicine and Phamarcy. 2021;16(DB4):54-58. https://doi.org/10.52389/ydls.v16iDB4.924